GENinCode (LON:GENI) Trading 110.2% Higher – Here’s What Happened

Shares of GENinCode Plc (LON:GENIGet Free Report) were up 110.2% on Thursday . The stock traded as high as GBX 6.95 ($0.09) and last traded at GBX 6.73 ($0.08). Approximately 7,091,908 shares changed hands during mid-day trading, an increase of 1,322% from the average daily volume of 498,732 shares. The stock had previously closed at GBX 3.20 ($0.04).

GENinCode Stock Performance

The firm has a market cap of £8.49 million, a PE ratio of -96.00 and a beta of 0.66. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27. The company has a 50-day simple moving average of GBX 3.85 and a two-hundred day simple moving average of GBX 5.14.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

See Also

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.